Do We Get Samples of the Report?

Yes, you will receive a sample copy of the market research report from the sales team when you put a query to us. The sample report is free and offers a brief view of the report and information on data available before you purchase the full-fledged report. Also, we will provide a demo sample for any oncoming study.

How to Buy a Market Report?

Select the report you wish to purchase and proceed to buy it by making an online payment. We use a secured gateway for payment transfers and do not share your financial information with any unconcerned third party.

In Which Format Will I Get the Report?

The report will be delivered in spreadsheet and PDF format. In some cases, PPT formats could be available as well.

In How Much Time I will Get the Report After Purchase?

After confirmation of the payment, you will receive the electronic format of the report at your registered email address in (mention the timeline for the delivery). If you buy a report over a holiday or weekend, we will process the request the next working day.

How Can I Get the Report Customized?

Market studies and reports already contain important data and are ready for distribution to the purchaser. However, if there is any particular query, addition, or customization you require, then contact us on our email id or phone. We will look to accommodate your request and see what can be done at the earliest. The research team will design the report accordingly and discuss the solutions beforehand with you.

How Much Will It Cost to Get a Report Customized?

The price of the customized report will be conveyed to you by our team after we agree on the deliverable. A delivery timeline will be set so that you get the report within the expected date. Any requests for customizations after selling the report will be handled by a separate department and the prices for the same mentioned upfront.

Can I Buy Only a Particular Segment of the Study?

While usually such a request is not accommodated as any market research report is wholesome and the cost of the report is for overall contents, in special cases, we may be able to sell select segments of the report based on your requirements.

Is There Any Available Discount?

Our team will love to support academicians, start-ups, students, and others with consulting and research. Thus, our pricing plan is based on keeping these interests in mind and is already affordable. However, we may have discounts available for particular customer types and reports. So, contact us for more information.

Which Services Are Complimentary Before Purchasing the Report?

We have consumer-centric reports and offer several facilities before selling. You will get a free review and sample report, talk to our customer care team for any additions to be done and meet special requirements, and interact with our analysts for deeper understanding.

Will I Receive a Bill or Invoice for the Report Purchased?

Yes, you will get an invoice for the purchase you made. The invoice will be sent to you electronically on your registered email id.

What If I am Unable to Find the Report in the Catalog?

We have a vast database of market reports and studies and there are a few which may not have been uploaded yet. If you are unable to find the one you want, then get in touch with our sales team by phone or email and we will connect with you for assistance.

How Often Are the Existing Studies Updated?

Not every study is the same. Thus, the update for reports will depend on the ongoing research and changes if any to be incorporated in the document or not.

What If the Report Does Not Contain the Information I Want?

The market research reports are constructed keeping in mind the industry trends, nature of the study, and required inputs. But if you want something more than what is stated in the report, we can help you out with further research if possible. Contact us right away, and we will do the needful to aid you.

Is the Payment Refundable?

Once the payment is done, it is non-refundable because as per the standard policy, the utility of the reports is based on knowledge sharing, and thus, a refund is not possible to make after we have issued you obtain the study. To avoid the hassle, we have a detailed view of the report and its ideas through a sample report.

What If the Payment Fails?

If the payment fails then be assured that you shall receive the money back to the source payment mode from the payment gateway. Aarkstore is not responsible for any loss of payment in the process.

Can I Avail the Report of a Particular Country/Region?

Yes, we can provide a report or segment related to a particular region or geography if we have that feature available for the document.

Do You Offer Support After Purchase?

Yes, we are here to solve any queries you may have for the report from our analyst till a given timeframe. To understand more about this, get in touch with us.

Pear Therapeutics Inc - Product Pipeline Analysis, 2019 Update

DESCRIPTION

TABLE OF CONTENTS

RELATED REPORTS

SAMPLE REQUEST

REVIEWS

DESCRIPTION

Summary

Pear Therapeutics Inc (Pear Therapeutics) develops software-based prescription digital therapeutics for the treatment of severe medical conditions and diseases. Its product pipeline includes reSET-O for treating opioid use disorder (OUD) in conjunction with opioid replacement therapy; Thrive designed for schizophrenia; reCALL using virtual reality exposure therapy to treat combat posttraumatic stress disorder (PTSD); reVIVE against general anxiety disorder; and PEAR-005 to PEAR-011 for treating pain, major depressive disorder, insomnia, Parkinsons disease and inflammatory conditions. Pear Therapeutics reSET, is an FDA-authorized prescription therapeutic for substance use disorder (SUD) used as an outpatient treatment. The company works in partnership with Center for Technology and Behavioral Health, Dartmouth College, Ehave, Inc., Intellectual Ventures Management LLC, Novartis AG, and others. Pear Therapeutics is headquartered in Boston, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Pear Therapeutics Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

TABLE OF CONTENTS

List of Tables
List of Figures
Pear Therapeutics Inc Company Overview
Pear Therapeutics Inc Company Snapshot
Pear Therapeutics Inc Pipeline Products and Ongoing Clinical Trials Overview
Pear Therapeutics Inc Pipeline Analysis Overview
Pear Therapeutics Inc - Key Facts
Pear Therapeutics Inc - Major Products and Services
Pear Therapeutics Inc Pipeline Products by Development Stage
Pear Therapeutics Inc Ongoing Clinical Trials by Trial Status
Pear Therapeutics Inc Pipeline Products Overview
Digital Therapeutic - Autism Spectrum Disorder
Digital Therapeutic - Autism Spectrum Disorder Product Overview
Digital Therapeutic - Cardiovascular Disease
Digital Therapeutic - Cardiovascular Disease Product Overview
Digital Therapeutic - Cognition
Digital Therapeutic - Cognition Product Overview
Digital Therapeutic - Epilepsy
Digital Therapeutic - Epilepsy Product Overview
Digital Therapeutic - Gastrointestinal Disease
Digital Therapeutic - Gastrointestinal Disease Product Overview
Digital Therapeutic - Inflammatory conditions
Digital Therapeutic - Inflammatory conditions Product Overview
Digital Therapeutic - Major Depressive Disorder
Digital Therapeutic - Major Depressive Disorder Product Overview
Digital Therapeutic - Movement Disorders
Digital Therapeutic - Movement Disorders Product Overview
Digital Therapeutic - Oncology
Digital Therapeutic - Oncology Product Overview
Digital Therapeutic - Respiratory
Digital Therapeutic - Respiratory Product Overview
PEAR-006 - Multiple Sclerosis
PEAR-006 - Multiple Sclerosis Product Overview
PEAR-006 - Multiple Sclerosis Clinical Trial
reCALL
reCALL Product Overview
reVIVE
reVIVE Product Overview
Somryst
Somryst Product Overview
Thrive
Thrive Product Overview
Thrive Clinical Trial
Pear Therapeutics Inc - Key Competitors
Pear Therapeutics Inc - Key Employees
Pear Therapeutics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Pear Therapeutics Inc, Recent Developments
May 18, 2019: Pear Therapeutics to present data on reSET, for the treatment of substance use disorder, and Pear-004, for the treatment of Schizophrenia, at American Psychiatric Association Annual Meeting
May 03, 2019: Pear Therapeutics initiates feasibility study to treat depressive symptoms in people with multiple sclerosis
Jan 07, 2019: Sandoz and Pear Therapeutics announce US launch of reSET-O to help treat opioid use disorder
Dec 17, 2018: Pear Therapeutics announces initiation of proof of concept study for prescription digital therapeutic in development for the treatment of Schizophrenia
Dec 11, 2018: Sandoz and Pear Therapeutics get FDA clearance for reSET-O app
Dec 05, 2018: Pear Therapeutics presents new data on reSET and reSET-O at American Academy of Addiction Psychiatry Annual Meeting and Scientific Symposium
Nov 20, 2018: Sandoz and Pear Therapeutics launch reSET for SUD patients
Jan 16, 2018: Magellan Health Continues Innovation and Efforts to Improve Outcomes for Patients with Substance Use Disorder
Dec 12, 2017: Pear Therapeutics Wins Fierce Innovation Life Science Award for reSET Prescription Digital Therapeutic
Oct 18, 2017: Pear Therapeutics Receives Expedited Access Pathway Designation from FDA for reSET-O Prescription Digital Therapeutic to Treat Opioid Use Disorder
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

List of Tables
Pear Therapeutics Inc Pipeline Products and Ongoing Clinical Trials Overview
Pear Therapeutics Inc Pipeline Products by Equipment Type
Pear Therapeutics Inc Pipeline Products by Indication
Pear Therapeutics Inc Ongoing Clinical Trials by Trial Status
Pear Therapeutics Inc, Key Facts
Pear Therapeutics Inc, Major Products and Services
Pear Therapeutics Inc Number of Pipeline Products by Development Stage
Pear Therapeutics Inc Pipeline Products Summary by Development Stage
Pear Therapeutics Inc Ongoing Clinical Trials by Trial Status
Pear Therapeutics Inc Ongoing Clinical Trials Summary
Digital Therapeutic - Autism Spectrum Disorder - Product Status
Digital Therapeutic - Autism Spectrum Disorder - Product Description
Digital Therapeutic - Cardiovascular Disease - Product Status
Digital Therapeutic - Cardiovascular Disease - Product Description
Digital Therapeutic - Cognition - Product Status
Digital Therapeutic - Cognition - Product Description
Digital Therapeutic - Epilepsy - Product Status
Digital Therapeutic - Epilepsy - Product Description
Digital Therapeutic - Gastrointestinal Disease - Product Status
Digital Therapeutic - Gastrointestinal Disease - Product Description
Digital Therapeutic - Inflammatory conditions - Product Status
Digital Therapeutic - Inflammatory conditions - Product Description
Digital Therapeutic - Major Depressive Disorder - Product Status
Digital Therapeutic - Major Depressive Disorder - Product Description
Digital Therapeutic - Movement Disorders - Product Status
Digital Therapeutic - Movement Disorders - Product Description
Digital Therapeutic - Oncology - Product Status
Digital Therapeutic - Oncology - Product Description
Digital Therapeutic - Respiratory - Product Status
Digital Therapeutic - Respiratory - Product Description
PEAR-006 - Multiple Sclerosis - Product Status
PEAR-006 - Multiple Sclerosis - Product Description
PEAR-006 - Multiple Sclerosis - Feasibility Study to Treat Depressive Symptoms in People with Multiple Sclerosis
reCALL - Product Status
reCALL - Product Description
reVIVE - Product Status
reVIVE - Product Description
Somryst - Product Status
Somryst - Product Description
Thrive - Product Status
Thrive - Product Description
Thrive - A Randomized, Sham-controlled Study of PEAR-004 as an Adjunct to Standard-of-care Treatment for Schizophrenia
Pear Therapeutics Inc, Key Employees
Pear Therapeutics Inc, Other Locations
Glossary

List Of Figures

List of Figures
Pear Therapeutics Inc Pipeline Products by Equipment Type
Pear Therapeutics Inc Pipeline Products by Development Stage
Pear Therapeutics Inc Ongoing Clinical Trials by Trial Status

RELATED REPORTS

Anika Therapeutics Inc (ANIK) - Product Pipeline Analysis, 2021 Update

Anika Therapeutics Inc (Anika) develops, manufactures, and markets therapeutic products for degenerative orthopedic diseases and traumatic conditions. It offers solutions for ortho-biologics, dermal, ophthalmic, surgical and veterinary applications. Its major

USD 750 View Report

Chinook Therapeutics Inc (KDNY) - Financial and Strategic SWOT Analysis Review

Chinook Therapeutics, Inc (Chinook)., formerly Aduro BioTech Inc is a clinical-stage immunotherapy company that discovers, develops and commercializes therapies for the treatment of cancer. The company develops product candidates using

USD 300 View Report

SAMPLE REQUEST

Fill The Form For Sample Request

Full Name*

Business Email *

E-mail

Country *

Contact No *

Alternate No

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

REVIEWS

There is no Reviews available

Search and Get the Latest Market Research Reports

Pear Therapeutics Inc - Product Pipeline Analysis, 2019 Update

Anika Therapeutics Inc (ANIK) - Product Pipeline Analysis, 2021 Update

Chinook Therapeutics Inc (KDNY) - Financial and Strategic SWOT Analysis Review

FAQs